Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Oct 15;69(9):1517-1525.
doi: 10.1093/cid/ciz429.

Chlamydia trachomatis and the Risk of Pelvic Inflammatory Disease, Ectopic Pregnancy, and Female Infertility: A Retrospective Cohort Study Among Primary Care Patients

Casper D J den Heijer  1   2 , Christian J P A Hoebe  2   3 , Johanna H M Driessen  1   4 , Petra Wolffs  3 , Ingrid V F van den Broek  5 , Bernice M Hoenderboom  5 , Rachael Williams  6 , Frank de Vries  1   4 , Nicole H T M Dukers-Muijrers  2   3
Affiliations

Chlamydia trachomatis and the Risk of Pelvic Inflammatory Disease, Ectopic Pregnancy, and Female Infertility: A Retrospective Cohort Study Among Primary Care Patients

Casper D J den Heijer et al. Clin Infect Dis. .

Erratum in

Abstract

Background: We evaluated the risk of pelvic inflammatory disease (PID), ectopic pregnancy, and infertility in women with a previous Chlamydia trachomatis (CT) diagnosis compared with women who tested negative for CT and CT untested women, considering both targeted and incidental (ie, prescribed for another indication) use of CT-effective antibiotics.

Methods: This was a retrospective study of women aged 12-25 years at start of follow-up within the Clinical Practice Research Datalink GOLD database linked to index of multiple deprivation quintiles, 2000-2013. CT test status and antibiotic use were determined in a time-dependent manner. Risk of PID, ectopic pregnancy, or female infertility were evaluated using of Cox proportional hazard models.

Results: We studied 857 324 women, contributing 6 457 060 person-years. Compared with women who tested CT-negative, women who tested CT-positive had an increased risk of PID (adjusted hazard ratio [aHR], 2.36; 95% confidence interval [CI], 2.01-2.79), ectopic pregnancy (aHR, 1.87; 95% CI, 1.38-2.54), and infertility (aHR, 1.85; 95% CI, 1.27-2.68). The PID risk was higher for women with 2 or more positive CT tests than those with 1 positive test. PID risk increased with the number of previous antibiotic prescriptions, regardless of CT test status.

Conclusions: We showed an association between CT-positive tests and 3 adverse reproductive health outcomes. Moreover, this risk increased with repeat CT infections. CT-effective antibiotic use showed no decreased risks of subsequent PID regardless of CT history. Our results confirm the reproductive health burden of CT, which requires adequate public health interventions.

Keywords: Chlamydia trachomatis; CPRD; adverse reproductive health; antibiotics.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Flow diagram of women included in the study per exclusion step. Abbreviations: CPRD, Clinical Practice Research Datalink; IMD, index of multiple deprivation; SES, socioeconomic status; UK, United Kingdom. *Numbers add up to more than the total number of women excluded in this step because a woman could have a history of more than 1 of the excluded conditions.
Figure 2.
Figure 2.
Classification of follow-up time according to CT test status and antibiotic use. Abbreviations: CT, Chlamydia trachomatis; PID, pelvic inflammatory disease. Never use = no antibiotic prescription was issued during follow-up; current use = the most recently recorded antibiotic prescription was issued in the past 3 months; recent use = the most recently recorded prescription was issued between 4 months and 3 years ago.
See this image and copyright information in PMC

References

    1. Hoenderboom BM, van Oeffelen AA, van Benthem BH, et al. . The Netherlands Chlamydia cohort study (NECCST) protocol to assess the risk of late complications following Chlamydia trachomatis infection in women. BMC Infect Dis 2017; 17:264. - PMC - PubMed
    1. Haggerty CL, Gottlieb SL, Taylor BD, Low N, Xu F, Ness RB. Risk of sequelae after Chlamydia trachomatis genital infection in women. J Infect Dis 2010; 201(Suppl 2):S134–55. - PubMed
    1. Oakeshott P, Kerry S, Aghaizu A, et al. . Randomised controlled trial of screening for Chlamydia trachomatis to prevent pelvic inflammatory disease: the POPI (prevention of pelvic infection) trial. BMJ 2010; 340:c1642. - PMC - PubMed
    1. Davies B, Turner KME, Frølund M, et al. ; Danish Chlamydia Study Group Risk of reproductive complications following chlamydia testing: a population-based retrospective cohort study in Denmark. Lancet Infect Dis 2016; 16:1057–64. - PubMed
    1. Reekie J, Donovan B, Guy R, et al. ; Chlamydia and Reproductive Health Outcome Investigators Risk of pelvic inflammatory disease in relation to chlamydia and gonorrhea testing, repeat testing, and positivity: a population-based cohort study. Clin Infect Dis 2018; 66:437–43. - PubMed

Publication types

Substances